Warfarin dose requirement in patients having severe thrombosis or thrombophilia.
Tuukka Antero HelinLotta Joutsi-KorhonenHeidi AsmundelaMikko NiemiArto OrpanaRiitta LassilaPublished in: British journal of clinical pharmacology (2019)
In severe thrombosis and/or thrombophilia, variation in thrombin generation and pharmacodynamics influences warfarin response. Pharmacogenetic dosing algorithms seem to underestimate dose requirement.